CardioFocus

CardioFocus is a medical device company based in Marlborough, Massachusetts, founded in 1990. The company specializes in innovative technologies for treating cardiac arrhythmias, particularly atrial fibrillation (AFib). CardioFocus provides electrophysiologists with advanced tools designed to enhance precision and efficiency in cardiac ablation procedures. The core product is the HeartLight Endoscopic Ablation System, which combines an ultra-compliant balloon with direct visualization and titratable laser energy. This system sets a new standard for AFib ablation by enabling precise pulmonary vein isolation and improving procedural success. Additionally, CardioFocus has developed the Centauri pulsed field ablation platform, utilizing proprietary waveform technology for high-precision lesion creation, currently available in the European Union. CardioFocus aims to improve patient outcomes by optimizing energy delivery during ablation, resulting in shorter procedure times and durable lesion formation. The company has treated over 10,000 patients worldwide and continues to focus on research and development to advance its technologies in cardiac electrophysiology.

• Employees 73
• Founded 1990
• Annual Revenue $22222000
• Total Funding $179354409